Specification of the terminal regions of the Drosophila embryo depends on the Torso RTK pathway, which triggers expression of the zygotic genes tailless and huckebein at the embryonic poles. However, it has been shown that the Torso signalling pathway does not directly activate expression of these zygotic genes; rather, it induces their expression by inactivating, at the embryonic poles, a uniformly distributed repressor activity. In particular, it has been shown that Torso signalling regulates accumulation of the Capicua transcriptional repressor: as a consequence of Torso signalling Capicua is downregulated specifically at the poles of blastoderm stage embryos. Extending the current model, we show that activation of the Torso pathway can trigger tailless expression without eliminating Capicua. In addition, analysis of gene activation by the Torso pathway and downregulation of Capicua unveil differences between the terminal and the central embryonic regions that are independent of Torso signalling, hitherto thought to be the only system responsible for confering terminal specificities. These data provide new insights into the mode of action of the Torso signalling pathway and on the events patterning the early Drosophila embryo. q
Introduction
The ability of cells to respond to extracellular signals relies on a set of mechanisms that are of widespread use in different developmental contexts and are highly conserved among different organisms. One such mechanism is based on the activation of receptor tyrosine kinases (RTKs) by secreted growth factors, which regulates cell proliferation and cell fate determination in many different cellular and developmental contexts. Activation of RTK signalling typically involves a common cytoplasmic cascade including Ras, and the serinethreonine kinases Raf, MAPKK/MEK and MAPK. However, the nuclear response to the signal depends in many cases on the availability of different transcription factors for direct phosphorylation by the Ras/Raf pathway.
The Drosophila torso (tor) gene codes for a RTK (Sprenger et al., 1989 ) that has been used as one of the model systems to genetically analyse the activity of those receptor signalling pathways. Tor activation at the embryonic poles is responsible for the expression of the genes tailless (tll) and huckebein (hkb). These genes initiate the developmental programmes giving rise to the most anterior and posterior terminal regions of the embryo (for a review see Furriols and Casanova, 2003; Li, 2005) . However, rather than regulating gene expression by direct activation, the Tor signalling pathway functions by inactivating at the embryonic poles a uniformly distributed repressor activity that involves the Groucho (Gro) corepresor (Liaw et al., 1995; Paroush et al., 1997) . Another component of this corepresor complex is the product of capicua (cic), which encodes a putative transcription factor with a DNA binding domain of the HMG box class and appears to be the target inhibited by the Tor signal. In particular, Cic protein is present in the nuclei of the central region of the embryo but downregulated in the nuclei at both poles. Downregulation of Cic at the poles is due to Tor signalling, as Cic is present in the nuclei at the poles in mutants impairing Tor signalling (Jiménez et al., 2000) . Cic activity is not restricted to embryonic terminal patterning as Cic also mediates follicle cell determination and wing vein patterning, acting as a repressor downregulated by the EGFR signalling pathway (Goff et al., 2001; Roch et al., 2002) . Similarly to Gro, Cic is also conserved in many organisms across evolution, suggesting that they could be part of a conserved repressor complex downregulated by the Ras/Raf molecular cassette in different cellular contexts (Jiménez et al., 2000; Lee et al., 2002) .
In this work, we analyze further the relation between gene activation by the Tor pathway and downregulation of Cic. Extending the current model, we show that activation of the Tor pathway is also able to trigger tll expression without eliminating Cic from the nucleus, in a context where Cic repression is still functional. We further show that downregulation of Cic by Tor signalling is embryonic regionspecific, unveiling a difference between central and terminal regions that is independent of Tor signalling, hitherto thought to be the only system responsible for confering terminal specificities. These data provide new insights into the mode of action of the Tor signalling pathway and on the events patterning the early Drosophila embryo.
Results and discussion

Tor signalling can not downregulate Cic protein in the embryonic middle regions
While the Tor pathway is normally activated only at the embryonic poles, tor constitutive mutations trigger its activation over the entire embryo in a ligand-independent manner (Klingler et al., 1988; Strecker et al., 1989; Casanova and Struhl, 1989) . In these cases, expression of the tor target genes is expanded too much broader domains (Fig. 1A ,C,E) and embryos develop head and tail structures lacking most of the segmented trunk. According to the current model one would expect that tll domain expansion in these mutations would be accompanied by an expansion of the Cic downregulation domain. In embryos from females bearing the tor D4021 constitutive mutation, tll expression is expanded but Cic distribution appears as in the wild-type. (E),(F) In embryos from females homozygous for the tor RL3 constitutive mutation, tll expression is also expanded but to a lesser degree than in a tor D4021 background; Cic distribution is also as in the wild-type. (G),(H) Ectopic activation of wild-type Torso receptors in embryos from females bearing a tubGAL4 and a UAStsl construct also leads to expansion of tll domain, but Cic distribution remains as in the wild-type. Insets are magnifications of the surface view to show nuclear localization of the Cic protein in the middle region of the embryos.
We have analyzed embryos from mutant females bearing the tor D4021 constitutive mutation (a strong gain-of-function mutation that acts as a dominant female sterile) and instead found that Cic protein is still downregulated only at the poles ( Fig. 1D) , as in the wild-type embryos (Fig. 1B) . Therefore, while in the wild-type the posterior tll domain is complementary to the domain of Cic accumulation (Fig. 1A,B) , in embryos from tor D4021 /Cfemales these domains overlap and tll is expressed in spite of the presence of nuclear Cic (Fig. 1C,D) . This behaviour is not allele-specific as embryos from homozygous females for another tor constitutive mutation (tor RL3 ) display the same kind of Cic distribution and tll expression (Fig. 1E,F) .
It has been postulated that wild-type Tor receptors and Tor receptors activated by ligand-independent constitutive mutations could signal through distinct downstream effectors (Li et al., 2002) . Therefore, we have analysed whether the persistent accumulation of Cic in embryos from tor constitutive mutant females could be due to a distinct property of these mutations. Alternatively, the persistent Cic accumulation could reflect a difference in response between Tor activation in the middle versus the terminal embryonic regions. To test these possibilities, we have triggered ligand-dependent activation of the Tor receptor over the entire embryo by general expression of the torso-like (tsl) gene. tsl is the only known gene in the Tor pathway whose expression is locally restricted (SavantBhonsale and Montell, 1993; Martin et al., 1994) . Indeed its restricted expression in a group of cells at each end of the developing oocyte is the determinant for the local activation of the Tor pathway, as its ectopic expression is sufficient to induce widespread activation of the Tor receptor (Savant-Bhonsale and Montell, 1993; Martin et al., 1994; Furriols et al., 1998) . Accordingly, we have found that driving tsl expression with a tubGAL4 driver in the oocyte gives rise to an expansion of the tll expression domain (Fig. 1G ) and to the generation of embryos with a tor-gain-of-function phenotype, in that they develop head and tail structures and lack most of the segmented trunk (Fig. 3C) . However, and similarly to what we described above for tor constitutive mutations, in these embryos Cic downregulation is not expanded to a broader domain (Fig. 1H) , indicating that even ligand-induced activation of the Tor pathway is unable to inhibit Cic protein accumulation in the embryonic middle regions.
Tor activation in the embryonic middle regions triggers tll expression without eliminating cic repression function
In the experiments described above activation of the Tor pathway over the whole embryo did not result in an expansion In these experiments, the tor RL3 genotype was examined in a trk background to eliminate ligand-induced activation (Casanova and Struhl, 1989 of Cic downregulation. Paradoxically, activated Tor could trigger downstream targets in the middle region even though Cic was still present. These observations raise the question of whether under these circumstances Cic is still able to act as a transcriptional repressor. Alternatively, Tor signalling could impair cic activity without removing Cic protein from the nuclei. To address this issue we have analyzed the contribution of cic function in embryos from tor constitutive mutants.
The strong transformations associated with the ectopic activation of the Tor pathway due to tor D4021 mutations and tubGAL4 driven expression of tsl (Fig. 3C and data not shown) make it difficult to assess the operational state of the Cic repressor under these circumstances. To overcome this difficulty we have made use of the weaker tor RL3 constitutive mutation and we have scored cuticular transformations, which are more sensitive to small changes in the expression of tor targets genes than what can be visualized by whole mount in situs. Besides, in the following experiments the tor RL3 genotype was examined in a trk background to eliminate ligand-induced activation (Casanova and Struhl, 1989) . On its own, a single copy of tor RL3 gives rise to a very mild phenotype, in which occasionally one abdominal segment is deleted ( Fig. 2A) . On the other hand, removing just one copy of the cic gene does not affect the embryonic pattern (Fig. 2B) . However, a single copy of the tor RL3 mutation combined with the removal of just one copy of the cic gene gives rise to prominent transformations; embryos from such females display variable phenotypes but in every case they show major deletions of the embryonic segments (Fig. 2C) . Accordingly, there is an expansion of the domain of tll expression, which also in that case overlaps with the domain where Cic accumulates (Fig. 2D,E) . In this situation, we can now assess whether nuclear Cic protein is still functional by removing the remaining copy of the cic gene and comparing the two phenotypes. Indeed, we have found that embryos from trk tor RL3 /C; cic/cic have a much stronger phenotype that those from trk tor RL3 /C; cic/C (Fig. 2C,F) . Therefore, the Cic protein present in trk tor RL3 /C; cic/C embryos is still at least in part functional implying that the tor RL3 mutation is able to trigger tll activation without eliminating all cic repression activity.
Tor signalling can trigger developmental targets in a manner independent of Cic downregulation
The phenotypes associated with tor constitutive mutations can be stronger than the ones associated with mutations in cic or in gro, its corepressor partner (Klingler et al., 1988; Paroush et al., 1997; Jiménez et al., 2000) . This is also the case for the phenotypes associated with ligand-dependent activation of the Tor receptor over the entire embryo obtained by general expression of the tsl gene (see Figs. 2G and 3C ). These observations already suggest that Tor signalling can activate its target genes by a mechanism other than just impairing Cic/Gro repression. To confirm this idea we have compared the phenotypes due to the lack of cic activity in either an otherwise wild-type background or in the presence of a copy of the tor RL3 constitutive mutation and found that the latter is indeed stronger (Fig. 2F,G and Table 1 ), indicating that Tor signalling can promote terminal fate in a manner independent of Cic downregulation.
Stat92E as a mediator of both ligand-dependent and constitutive activation of the Tor receptor
We wished to ask what mechanisms are activated by Tor signalling that could bypass the need for Cic downregulation to activate terminal target genes. It has been suggested that the Stat92E transcription factor plays a role as a mediator of Tor signalling elicited by a Tor constitutive mutant receptor, but not in Tor signalling promoted by ligand-dependent activation of the receptor at the poles (Li et al., 2002) . We have assessed the role of Stat92E in our tor constitutive mutant background. We find a significant a reduction in the transformations associated with the trk tor RL3 /C; cic/C genotype by removing a single copy of the stat92E gene (Fig. 3A,B and Table 1 ). We then analysed whether this could also apply in the case of ectopic activation of the Tor pathway through ligand binding and found that also in this case there is a reduction of the strength of the phenotype (Fig. 3C,D and Table 1 ). In this case, however, the reduction is smaller, which could be due to the fact that the original transformation generated by the tubGAL4/ UAStsl combination is much stronger and/or to a weaker involvement of stat92E in ligand-induced Tor signalling. Regardless, our results suggest that there is no fundamental difference in the role of stat92E between ligand-induced or constitutive activation of the Tor receptor. In support of this conclusion there is the recent observation that Stat92E is specifically phosphorylated at the poles by ligand-induced Tor signalling (Li et al., 2003) . Therefore, similarly to what we have observed in the embryonic middle regions, we propose that Tor could also induce tll activation in the poles by a Cic downregulation-independent mechanism via stat92E. Altogether these results suggest that Tor signalling could normally trigger tll expression at the poles of wild-type embryos by two kind of regulatory mechanisms, relief of cic repression and positive activation of tll expression. The positive effect of Tor signalling on tll expression could have been obscured by the fact that there is also a still unidentified Tor-independent activator as terminal fate is specified in embryos lacking both Tor signalling and Cic repression (Jiménez et al., 2000) . Accordingly, it has to be noted that stat92E mutants suppress ectopic activation of tll in the middle embryonic regions but not tll activation at the poles (Li et al., 2002) , which suggests that the role of stat92E on Tor signalling could be somehow redundant at the poles but absolutely required when Tor signalling is triggered in the embryonic middle regions.
Conclusions
The following conclusions can be drawn from our results. First, while activation of the Tor pathway at the embryonic poles downregulates Cic, Tor signalling appears to be necessary but not sufficient to eliminate Cic protein, as it can do so only at the embryonic poles. In this regard, it has to be noted that recent results indicate that the posterior maternal system can also affect Cic downregulation (Cinnamon et al., 2004) . Second, impairment of Cic repressor function is not an absolute requirement for tll expression, as tll can be expressed in situations where Cic repressor is still functional. In this regard, tll expression appears to be the result of a balance between repressor and activator factors and Cic repression might be overcome provided that activation is enhanced. And finally, there are differences between the terminal and the central embryonic regions that are independent of Tor signalling, as judged by the spatially restricted capacity of the Tor pathway to inhibit Cic accumulation and by the apparently distinct regional redundancy of stat92E function in Tor-dependent patterning. These results suggest that the Tor signalling pathway is not the only system that establishes a difference between the terminal and the central regions of the Drosophila embryo.
Experimental procedures
Fly strains
We have used the alleles cic 1 , stat92E
06346
, trk 1 , tor D4021 and tor
RL3
. Description of these can be found at at http://flybase.net (Flybase). As tor RL3 is a temperature-sensitive mutation, special attention was taken that all experiments with this mutation were performed at the same temperature of 25 8C. Ectopic expression of tsl was achieved with the GAL4 system (Brand and Perrimon, 1993 ) using a UAStsl (Stevens et al., 2003) and a tubGAL4 line (Januschke et al., 2002) .
Preparation of embryonic cuticle
For the analysis of embryonic cuticle, late embryos were removed from the chorion and usually also from the vitelline membrane and mounted in a mixture of Hoyer's medium (van der Meer, 1977) and lactic acid (1:1).
Immunochemistry and in situ hybridization
Embryos were stained according to standard protocols using the Vectastain ABC kit. Whole mount in situ hybridization was done following the method of Tautz and Pfeifle (1989) with minor modifications. We used an anti-cic antibody generated in our laboratory. A tll probe was generated from a clone (Casanova and Struhl, 1989) ) or with activation of the Tor pathway through ligand binding (UAStsl; tubGAL4) and it was compared to the same situations when a single copy of the stat92E gene was removed. In both cases, there is a significant (P!0.01) reduction in the associated transformations. (B) Embryos from tor RL3 /C; cic K have a stronger phenotype that those from cic K mutants. In a similar experiment, the number of abdominal segments was mesured in embryos from homozygous cic mutants and compared to that of embryos from homozygous cic mutants that had also a copy of the tor RL3 mutation (as in the above experiments, the tor RL3 genotype was examined in a trk background to eliminate ligand-induced activation (Casanova and Struhl, 1989) ). In all cases, there is a significant (P!0.01) reduction in the associated transformations. We have added mesures of the number of abdominal segments in embryos from other phenotypes as controls.
containing a tll cDNA (from J. Lengyel). Photographs were taken using a Normarski optic in a Nikon Eclipse 80i microscope.
